Derma Sciences (DSCI) Posts Q1 Loss of 24c/Share, Misses by 8c

Derma Sciences (NASDAQ: DSCI) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $16.33 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c